Figure 2
From: Characterization and identification of PARM-1 as a new potential oncogene
Schematic representation of full-length and deletion mutant constructs of mPARM-1 and hPARM-1. (a and b) Full-length constructs of the mouse (296 a.a) and human PARM-1 (310 a.a). (c to g) representation of the human deletion mutants. SP: signal peptide: (1–20 a.a), EC: extracellular domain (mPARM-1: 20–246 a.a; hPARM-1: 20–260 a.a), TM: transmembrane domain (mPARM-1: 246–266 a.a; hPARM-1: 260–280 a.a), and CT: cytoplasmic tail (mPARM-1: 266–296 a.a; hPARM-1: 280–310 a.a). EGFP was fused in the C-terminal end of all constructs.